Hypoxia and Inflammation in Prostate Cancer Progression. Cross-talk with Androgen and Estrogen Receptors and Cancer Stem Cells

Publisher： Bentham Science Publishers

E-ISSN： 2212-3873|16|4|235-248

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.16, Iss.4, 2017-02, pp. : 235-248

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cross-Talk Between the Androgen Receptor and the Phosphatidylinositol 3-Kinase/Akt Pathway in Prostate Cancer

By  

Current Cancer Drug Targets, Vol. 7, Iss. 6, 2007-09 ,pp. : 591-604

Bentham Science Publishers

Access to resources Recommend Favorite

Interlinking of Hypoxia and Estrogen in Thyroid Cancer Progression

By  

Current Medicinal Chemistry, Vol. 21, Iss. 11, 2014-04 ,pp. : 1351-1360

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Sensing Peptides in the Cross-talk between Microbiota and Human Cancer Cells

By  

Mini Reviews in Medicinal Chemistry, Vol. 18, Iss. 18, 2018-11 ,pp. : 1567-1571

Bentham Science Publishers

Access to resources Recommend Favorite

Semaphorins and their Receptors in Stem and Cancer Cells

By  

Current Medicinal Chemistry, Vol. 17, Iss. 30, 2010-10 ,pp. : 3462-3475

Bentham Science Publishers

Access to resources Recommend Favorite

Androgen Receptor Gene Rearrangements: New Perspectives on Prostate Cancer Progression

By  

Current Drug Targets, Vol. 14, Iss. 4, 2013-04 ,pp. : 441-449

Bentham Science Publishers

Access to resources Recommend Favorite